SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-14-103478
Filing Date
2014-03-18
Accepted
2014-03-18 08:47:08
Documents
3
Period of Report
2014-03-17
Items
Item 2.02: Results of Operations and Financial Condition
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d694462d8k.htm 8-K 18443
2 EX-99.1 d694462dex991.htm EX-99.1 55807
3 GRAPHIC g694462img001.jpg GRAPHIC 15526
  Complete submission text file 0001193125-14-103478.txt   97060
Mailing Address 800 CHESAPEAKE DRIVE REDWOOD CITY CA 94063
Business Address 800 CHESAPEAKE DRIVE REDWOOD CITY CA 94063 650-995-8200
OncoMed Pharmaceuticals Inc (Filer) CIK: 0001302573 (see all company filings)

IRS No.: 383572512 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35993 | Film No.: 14699432
SIC: 2834 Pharmaceutical Preparations